Imperial College London

Coronavirus mutations offer insights into virus evolution

by

Coronavirus particle

Researchers have characterised patterns of diversity of SARS-CoV-2 by analysing virus genomes from over 7,500 people infected with COVID-19.

The findings may offer clues to direct drugs and vaccine targets.

This study shows the great benefits of scientific collaboration and worldwide data sharing Dr Arturo Torres Ortiz Study author

The study team, led by the UCL Genetics Institute and featuring Imperial scientists, identified close to 200 recurrent genetic mutations in the virus, highlighting how it may be adapting and evolving to its human hosts.

Researchers found that a large proportion of the global genetic diversity of SARS-CoV-2 is found in all hardest-hit countries, suggesting extensive global transmission from early on in the epidemic and the absence of single ‘Patient Zeroes’ in most countries.

The findings, published today in Infection, Genetics and Evolution, also further establish the virus only emerged recently in late 2019, before quickly spreading across the globe.

Scientists analysed the emergence of genomic diversity in SARS-CoV-2, the new coronavirus causing Covid-19, by screening the genomes of over 7,500 viruses from infected patients around the globe. They identified 198 mutations that appear to have independently occurred more than once, which may hold clues to how the virus is adapting.

Co-lead author Professor Francois Balloux (UCL Genetics Institute) said: “All viruses naturally mutate. Mutations in themselves are not a bad thing and there is nothing to suggest SARS-CoV-2 is mutating faster or slower than expected. So far we cannot say whether SARS-CoV-2 is becoming more or less lethal and contagious.”

Dr Arturo Torres Ortiz, study author from Imperial's Department of Infectious Disease, added: "This study shows the great benefits of scientific collaboration and worldwide data sharing, as all the samples included were made readily accessible by researchers all around the world. The paper proposes a set of mutations that seem to occur independently multiple times since the emergence of the virus, and although it is still too early to describe potential functional consequences of such mutations, they represent good candidates for further research.”

The small genetic changes, or mutations, identified were not evenly distributed across the virus genome. As some parts of the genome had very few mutations, the researchers say those invariant parts of the virus could be better targets for drug and vaccine development.

Vaccine development

“A major challenge to defeating viruses is that a vaccine or drug might no longer be effective if the virus has mutated. If we focus our efforts on parts of the virus that are less likely to mutate, we have a better chance of developing drugs that will be effective in the long run,” Professor Balloux explained.

“We need to develop drugs and vaccines that cannot be easily evaded by the virus.”

Co-lead author Dr Lucy van Dorp (UCL Genetics Institute) added: “There are still very few genetic differences or mutations between viruses. We found that some of these differences have occurred multiple times, independently of one another during the course of the pandemic – we need to continue to monitor these as more genomes become available and conduct research to understand exactly what they do.”

The results add to a growing body of evidence that SARS-CoV-2 viruses share a common ancestor from late 2019, suggesting that this was when the virus jumped from a previous animal host, into people. This means it is most unlikely the virus causing Covid-19 was in human circulation for long before it was first detected.

In many countries including the UK, the diversity of viruses sampled was almost as much as that seen across the whole-world, meaning the virus entered the UK numerous times independently, rather than via any one index case.

The research team have developed a new interactive, open-source online application so that researchers across the globe can also review the virus genomes and apply similar approaches to better understand its evolution.

Dr van Dorp said: “Being able to analyse such an extraordinary number of virus genomes within the first few months of the pandemic could be invaluable to drug development efforts, and showcases how far genomic research has come even within the last decade. We are all benefiting from a tremendous effort by hundreds of researchers globally who have been sequencing virus genomes and making them available online.”

-

'Emergence of genomic diversity and recurrent mutations in SARS-CoV-2’ is published in Infection, Genetics and Evolution

Reporter

Kate Wighton

Kate Wighton
Communications and Public Affairs

Click to expand or contract

Contact details

Tel: +44 (0)20 7594 2409
Email: k.wighton@imperial.ac.uk

Show all stories by this author

Tags:

Research, Coronavirus
See more tags

Leave a comment

Your comment may be published, displaying your name as you provide it, unless you request otherwise. Your contact details will never be published.